Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells - Wikidata - awgldk - TriplyDB

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

http://www.wikidata.org/entity/Q26851971

about

Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases Fibroblasts in fibrosis: novel roles and mediators Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features.Protease activated receptor-1 deficiency diminishes bleomycin-induced skin fibrosis.Immune-Mediated Repair: A Matter of Plasticity.A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.Strategy for treatment of fibrosis in systemic sclerosis: Present and future.Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?Current and future direction in the management of scleroderma.The molecular pathogenesis of morphoea: from genetics to future treatment targets.Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases Pathogenesis of systemic sclerosis-current concept and emerging treatments.Pathophysiological Mechanisms in Sclerosing Skin Diseases.Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90 Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing.α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis.Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy.Endothelial-to-mesenchymal transition in cardiovascular diseases: Developmental signaling pathways gone awry.Test of Antifibrotic Drugs in a Cellular Model of Fibrosis Based on Muscle-Derived Fibroblasts from Duchenne Muscular Dystrophy Patients.Human Fibrotic Diseases: Current Challenges in Fibrosis Research.Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression.Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.Right Ventricle Remodeling and Function in Scleroderma Patients.IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases.Role of the mTOR pathway in minor salivary gland changes in Sjogren's syndrome and systemic sclerosis

P2860

Q26748338-91D78166-5482-42FA-B282-BD03725B495F Q26998508-DBE59FA1-5BAF-4581-80D8-AA73E69FB2B8 Q28390104-9FC1B32F-D824-495A-8096-9EFFCD35CCF0 Q33603627-6ABA2BD7-EA86-4E57-B196-7661505F4FCD Q33982509-9C5ED6A3-8919-4D0C-AEFE-26513AD36009 Q34389943-08E5F50D-2E0E-45CF-9C87-3902228FA4C4 Q34416229-8C80E4A3-FFD6-48FE-855C-4B1BFA130497 Q34556402-2E65F934-564A-439D-848A-D27D22C830EC Q35587696-248386CA-CAE2-409B-8DCF-C332F4D39877 Q35770782-007B5BF0-6705-4873-9AA0-FB39641E6AEC Q36591533-D4A8BEC2-89B9-4628-B305-19398125E67E Q37224668-669E2D88-5B80-487E-9AD9-64EC13CB4DD3 Q37381549-1305D3E5-516E-4F7C-9FD4-3BBB26479177 Q38187607-CFF131B5-8F7C-43C5-88E0-27C3D93BD59D Q38701990-9D9EBA69-8D12-4D7B-B046-C3061EFF4FC7 Q38710580-7E465996-EDCA-49E0-8E79-0613185684CE Q38823948-9BBA7883-180D-48A5-8049-B945FDF612DE Q38828584-2E6478CB-5E7C-488D-AD5E-73AFD796122A Q38936954-C69A1BC1-A492-4A31-BC82-274D62A25C56 Q39211384-CE22726D-547A-4A98-989F-0DF489E45111 Q39294794-CE0A2FB1-0916-4B39-B139-FBBCC08A28CC Q41462744-CFFA177E-4FFE-4E9E-A0DF-D6A4F8807DB3 Q41630154-C1316D10-84E9-44A5-82E1-11562061FA46 Q41811106-DDFE0C8A-C236-446B-8D68-92951716BD05 Q42075625-F5CB574C-5B56-444F-9F80-6ED5BD4AAB5E Q47133681-401C58FE-5A36-43CD-B776-93915D2F5B77 Q48096975-BC708299-03BD-4C00-9DD1-5E906FB5D696 Q50079567-B2846A0A-2C87-4051-B6D8-A979D87924F7 Q52536468-372D0673-8FD5-4F4E-89F1-C51D40F1BCAA Q52605977-7AD0C255-DDCB-4764-9040-3CB0ACE67935 Q52973999-7879C7C4-8FF5-4103-A548-9662F2971820 Q55153213-35AD6D62-D1E8-4C80-B714-818CBA737DC2 Q55283549-BCC4F52E-1ACE-491A-9150-050EEE735758 Q58800566-A74B4249-2F72-45DA-9DB0-14FDC5EC1FD8

P2860

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

http://www.wikidata.org/entity/Q26851971

description

2013 nî lūn-bûn

@nan

2013 թուականին հրատարակուած գիտական յօդուած

@hyw

2013 թվականին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

@ast

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

@en

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

@nl

type

label

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

@ast

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

@en

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

@nl

prefLabel

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

@ast

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

@en

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

@nl

P1433

Q26851971-8DC28323-4E81-4CA4-A9B9-E04EDBC3EE63

P1476

Q26851971-2641A46D-3DEE-434B-A8BB-54F2DEF05F96

P2093

Q26851971-06E63FDF-52CE-4060-8F43-3A53F684F085

Q26851971-423D4301-E030-4963-9C4A-48AC458D8E3F

Q26851971-736576BD-3F40-461B-B76D-8305B6DD746B

P2860

Q26851971-041C194E-ADED-4C3C-AC77-10891530529F

Q26851971-06C34043-737F-4583-AC54-31FD58122574

Q26851971-1607FDF0-66FE-401A-9231-2C7489814CCE

Q26851971-24B88EE9-9D69-4930-BEFD-AF7218E8180C

Q26851971-264EBCE5-73EC-46BE-84A6-62FD55906476

Q26851971-2C188965-16A2-4410-8AB8-FB8BD3841F8E

Q26851971-2C9D3003-8301-4E07-A3B3-9B28D411ABEE

Q26851971-2DA88CF8-4205-4965-86A2-A0D5DE452667

Q26851971-40CC5436-5E80-4962-9A8D-C20947EEA16E

Q26851971-451E310F-5104-461B-8385-3F5A8DD2C0EB

P2888

Q26851971-7C051000-2B5C-402E-B146-2F25683C9E41

P304

Q26851971-40955F4F-30D3-4E32-896D-2376553685BF

P31

Q26851971-8CA7E0D9-7F72-4DDB-A515-6DD1AAE1F3C7

Q26851971-A505551A-7E03-4AA7-BA0D-486CB796CB89

P3181

Q26851971-0D9AB89F-5C96-44F8-87A1-A21F36229038

P356

Q26851971-40B67398-1470-4BB0-BBB0-B89636B22C89

P407

Q26851971-8F34934B-C8AB-443A-ACC4-F073D6E53181

P433

Q26851971-3DB3AF2E-FB8E-4ECC-9CEB-0FE6B098ACC9

P478

Q26851971-9EC3A1EC-59CE-452D-8496-504111DBD2AB

P577

Q26851971-90FAAF11-B53B-4C1F-A5FA-F0D7F6AB4E5E

P5875

Q26851971-2C172C25-6DBF-4D54-9610-22332C096D83

P6179

Q26851971-B16C8C2C-8204-41B4-B3CB-5ACB30B05C25

P698

Q26851971-D84AD17F-F882-47D6-82A6-5666400E1184

P921

Q26851971-3DFE2B6B-2AE8-4379-A24D-72CDDE087368

Q26851971-490DD591-4F4A-4DF1-BEDA-8B232D26FBF2

Q26851971-AE3101AE-FDDF-4914-9EA3-B15A7916378F

P932

Q26851971-C063E60C-50FA-4D50-BE4F-BB2984A55132

P3181

P356

P1433

Arthritis Research and Therapy

P1476

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

@en

P2093

Adrian J Gilbane

http://www.w3.org/2001/XMLSchema#string

Alan M Holmes

http://www.w3.org/2001/XMLSchema#string

Christopher P Denton

http://www.w3.org/2001/XMLSchema#string

P2860

The myofibroblast: one function, multiple origins

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

Myofibroblasts and mechano-regulation of connective tissue remodelling

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

Mutations affecting segment number and polarity in Drosophila

Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

TGF-beta signaling and the fibrotic response

The role of fibrocytes in sickle cell lung disease.

Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma.

P2888

P304

215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1373033

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/AR4230

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

241696115

http://www.w3.org/2001/XMLSchema#string

P6179

1032324177

http://www.w3.org/2001/XMLSchema#string

P698

23796020

http://www.w3.org/2001/XMLSchema#string

P921

systemic scleroderma

P932

4060542

http://www.w3.org/2001/XMLSchema#string